0001469709-21-000077.txt : 20211217 0001469709-21-000077.hdr.sgml : 20211217 20211217154058 ACCESSION NUMBER: 0001469709-21-000077 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211217 DATE AS OF CHANGE: 20211217 EFFECTIVENESS DATE: 20211217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AngioGenex, Inc. CENTRAL INDEX KEY: 0001085596 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860945116 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-425689 FILM NUMBER: 211501314 BUSINESS ADDRESS: STREET 1: 425 MADISON AVENUE, SUITE 902 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-874-6608 MAIL ADDRESS: STREET 1: 425 MADISON AVENUE, SUITE 902 CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: ECLIC INC/NV DATE OF NAME CHANGE: 19990430 D 1 primary_doc.xml X0708 D LIVE 0001085596 AngioGenex, Inc. 425 MADISON AVENUE, SUITE 902 NEW YORK NY NEW YORK 10017 646-642-0701 NEVADA ECLIC INC ECLIC INC/NV Corporation true Michael Aronstein 425 MADISON AVENUE, SUITE 902 New York NY NEW YORK 10017 Executive Officer Director Martin Murray 425 MADISON AVENUE, SUITE 902 New York NY NEW YORK 10017 Executive Officer Director Michael Strage 425 MADISON AVENUE, SUITE 902 New York NY NEW YORK 10017 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2021-12-17 false true true false 0 260000 260000 0 false 1 0 0 0 true AngioGenex, Inc. /s/ Michael Aronstein Michael Aronstein Chief Executive Officer 2021-12-17